Reference health

CD8+ T Cell/Cancer-Associated Fibroblasts Ratio Stratifies Prognostic and Predictive Responses to Immunotherapy Across Multiple Cancer Types

https://doi.org/10.2139/ssrn.4141239
CiteStamped reference-health badge
34/34 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

7 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 34 checked references that resolve
resolves10.1152/physrev.00008.2020
Moving immune therapy forward targeting tme
resolves10.1158/2159-8290.CD-20-1808
Therapeutic Targeting of the Tumor Microenvironment
resolves10.1038/s41571-021-00546-5
Clinical and therapeutic relevance of cancer-associated fibroblasts
resolves10.1038/s41568-019-0238-1
A framework for advancing our understanding of cancer-associated fibroblasts
resolves10.1097/PAP.0000000000000161
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors
resolves10.3390/cancers12092687
Cancer-Associated Fibroblast Mediated Inhibition of CD8+ Cytotoxic T Cell Accumulation in Tumours: Mechanisms and Therapeutic Opportunities
resolves10.1038/s41467-018-03347-0
Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T Cells to protect tumour cells
resolves10.1016/j.celrep.2020.107628
Single-Cell RNA Sequencing Reveals a Dynamic Stromal Niche That Supports Tumor Growth
resolves10.3389/fimmu.2019.00847
Human Pancreatic Carcinoma-Associated Fibroblasts Promote Expression of Co-inhibitory Markers on CD4+ and CD8+ T-Cells
resolves10.1038/nmeth.3337
Robust enumeration of cell subsets from tissue expression profiles
resolves10.1038/ncomms3612
Inferring tumour purity and stromal and immune cell admixture from expression data
resolves10.3389/fimmu.2020.01218
Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma
resolves10.3390/cancers12113238
Prognostic Interactions between FAP+ Fibroblasts and CD8a+ T Cells in Colon Cancer
resolves10.1007/s12064-012-0162-3
Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples
resolves10.1093/biostatistics/kxj037
Adjusting batch effects in microarray expression data using empirical Bayes methods
resolves10.1016/j.immuni.2013.10.003
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
resolves10.1038/nature08460
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
resolves10.1056/NEJMoa1501824
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
resolves10.1073/pnas.0506580102
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
resolves10.1016/j.cels.2015.12.004
The Molecular Signatures Database Hallmark Gene Set Collection
resolves10.1016/j.cell.2014.12.033
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
resolves10.1056/NEJMoa1606774
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
resolves10.1038/s41571-021-00473-5
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
resolves10.1056/NEJMp1709968
First FDA Approval Agnostic of Cancer Site — When a Biomarker Defines the Indication
resolves10.1016/j.annonc.2020.07.002
The FDA approval of pembrolizumab for adult and pediatric patients with tumor mutational burden (TMB) ≥10: a decision centered on empowering patients and their physicians
resolves10.1016/j.ccell.2020.10.001
The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker
resolves10.1016/j.jtho.2020.05.019
The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee
resolves10.1016/j.annonc.2021.02.006
High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types
resolves10.1152/physrev.00048.2019
Diversity and Biology of Cancer-Associated Fibroblasts
resolves10.1111/cas.14346
Cancer‐associated fibroblasts that restrain cancer progression: Hypotheses and perspectives
resolves10.1038/s41573-018-0004-1
Turning foes to friends: targeting cancer-associated fibroblasts
resolves10.1038/s41568-019-0235-4
CD8+ T cell states in human cancer: insights from single-cell analysis
resolves10.1126/science.1235487
Heterogeneous Differentiation Patterns of Individual CD8 <sup>+</sup> T Cells
resolves10.1016/j.immuni.2020.04.007
Heterogenous Populations of Tissue-Resident CD8+ T Cells Are Generated in Response to Infection and Malignancy
The 7 references without a DOI — listed, not checked
no DOI — not checkedData curation, Formal analysis, Investigation. Longfeng Zhang
no DOI — not checkedCrosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives
no DOI — not checkedEstimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
no DOI — not checkedref15
no DOI — not checkedA new thinking: extended application of genomic selection to screen multiomics data for development of novel hypoxia-immune biomarkers and target therapy of clear cell renal cell carcinoma
no DOI — not checkedTumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures
no DOI — not checkedIFN-?-related mRNA profile predicts clinical response to PD-1 blockade
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.2139/ssrn.4141239"><img src="https://citestamp.com/citestamped/10.2139/ssrn.4141239/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.2139/ssrn.4141239/badge.svg)](https://citestamp.com/citestamped/10.2139/ssrn.4141239)